UroGen Pharma Ltd. (NASDAQ:URGN) Given Consensus Recommendation of "Moderate Buy" by Brokerages
MarketBeat
Shares of UroGen Pharma Ltd. (NASDAQ:URGN - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eight ratings firms that are currently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, five have given
NASDAQ:URGN